Rxcount Corp is categorized under Pharmaceutical Machinery Manufacturers in Irvine, CA and active since 1979.
Rxcount Corp was established in 1979, and today employs 1 to 4, earning Unknown per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Adam James, Marketing at the company’s single location by writing to 17945 Sky Park Circle # B, Irvine, California CA 92614 or by phoning (949) 250-4225. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rxcount Corp |
| Contact Person: | Adam James, Marketing |
| Address: | 17945 Sky Park Circle # B, Irvine, California 92614 |
| Phone Number: | (949) 250-4225 |
| Website Address: | rxcount.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Machinery Manufacturers |
| SIC Code: | 3559 |
| NAICS Code: | 9999900 |
| Share This Business: |
Rxcount Corp was started in 1979 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code 3559 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Adam James, Marketing for inquiries that concern Rxcount Corp by calling the company number (949) 250-4225, as your correspondence is most welcome. Additionally, the physical location of the single location of Rxcount Corp can be found at the coordinates 33.68985,-117.86086 as well as the street address 17945 Sky Park Circle # B in Irvine, California 92614.
For its online presence, you may visit Rxcount Corp’s website at rxcount.com and engage with its social media outlets through on Twitter and on Facebook.